BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15313894)

  • 21. A comparison of morphologic features, flow cytometry, TCR-Vbeta analysis, and TCR-PCR in qualitative and quantitative assessment of peripheral blood involvement by Sézary syndrome.
    Morice WG; Katzmann JA; Pittelkow MR; el-Azhary RA; Gibson LE; Hanson CA
    Am J Clin Pathol; 2006 Mar; 125(3):364-74. PubMed ID: 16613339
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Depressed IL-12-mediated signal transduction in T cells from patients with Sézary syndrome is associated with the absence of IL-12 receptor beta 2 mRNA and highly reduced levels of STAT4.
    Showe LC; Fox FE; Williams D; Au K; Niu Z; Rook AH
    J Immunol; 1999 Oct; 163(7):4073-9. PubMed ID: 10491012
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
    Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R
    Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Promoter-Specific Hypomethylation Is Associated with Overexpression of PLS3, GATA6, and TWIST1 in the Sezary Syndrome.
    Wong HK; Gibson H; Hake T; Geyer S; Frederickson J; Marcucci G; Caligiuri MA; Porcu P; Mishra A
    J Invest Dermatol; 2015 Aug; 135(8):2084-2092. PubMed ID: 25806852
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sézary syndrome without erythroderma.
    Henn A; Michel L; Fite C; Deschamps L; Ortonne N; Ingen-Housz-Oro S; Marinho E; Beylot-Barry M; Bagot M; Laroche L; Crickx B; Maubec E
    J Am Acad Dermatol; 2015 Jun; 72(6):1003-9.e1. PubMed ID: 25981000
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The mutational landscape of cutaneous T cell lymphoma and Sézary syndrome.
    da Silva Almeida AC; Abate F; Khiabanian H; Martinez-Escala E; Guitart J; Tensen CP; Vermeer MH; Rabadan R; Ferrando A; Palomero T
    Nat Genet; 2015 Dec; 47(12):1465-70. PubMed ID: 26551667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BCL2 and JUNB abnormalities in primary cutaneous lymphomas.
    Mao X; Orchard G; Lillington DM; Child FJ; Vonderheid EC; Nowell PC; Bagot M; Bensussan A; Russell-Jones R; Young BD; Whittaker SJ
    Br J Dermatol; 2004 Sep; 151(3):546-56. PubMed ID: 15377339
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-21 expression in CD4+ T cells is regulated by STAT3 and is pathologically involved in Sézary syndrome.
    van der Fits L; van Kester MS; Qin Y; Out-Luiting JJ; Smit F; Zoutman WH; Willemze R; Tensen CP; Vermeer MH
    J Invest Dermatol; 2011 Mar; 131(3):762-8. PubMed ID: 21085192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings.
    Ponti R; Quaglino P; Novelli M; Fierro MT; Comessatti A; Peroni A; Bonello L; Bernengo MG
    Br J Dermatol; 2005 Sep; 153(3):565-73. PubMed ID: 16120144
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of twist and wnt in human breast cancer.
    Watanabe O; Imamura H; Shimizu T; Kinoshita J; Okabe T; Hirano A; Yoshimatsu K; Konno S; Aiba M; Ogawa K
    Anticancer Res; 2004; 24(6):3851-6. PubMed ID: 15736421
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of Immunophenotypic and Molecular Biomarkers for Sézary Syndrome Using Standard Operating Procedures: A Multicenter Study of 59 Patients.
    Boonk SE; Zoutman WH; Marie-Cardine A; van der Fits L; Out-Luiting JJ; Mitchell TJ; Tosi I; Morris SL; Moriarty B; Booken N; Felcht M; Quaglino P; Ponti R; Barberio E; Ram-Wolff C; Jäntti K; Ranki A; Bernengo MG; Klemke CD; Bensussan A; Michel L; Whittaker S; Bagot M; Tensen CP; Willemze R; Vermeer MH
    J Invest Dermatol; 2016 Jul; 136(7):1364-1372. PubMed ID: 26930587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of EphA4 gene and reduced expression of EphB2 gene correlates with liver metastasis in colorectal cancer.
    Oshima T; Akaike M; Yoshihara K; Shiozawa M; Yamamoto N; Sato T; Akihito N; Nagano Y; Fujii S; Kunisaki C; Wada N; Rino Y; Tanaka K; Masuda M; Imada T
    Int J Oncol; 2008 Sep; 33(3):573-7. PubMed ID: 18695888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of PLS3, Twist, CD158k/KIR3DL2, and NKp46 gene expression combination for reliable Sézary syndrome diagnosis.
    Michel L; Jean-Louis F; Begue E; Bensussan A; Bagot M
    Blood; 2013 Feb; 121(8):1477-8. PubMed ID: 23429988
    [No Abstract]   [Full Text] [Related]  

  • 34. Detection of clonal T-cell receptor gamma gene rearrangements with the use of the polymerase chain reaction in cutaneous lesions of mycosis fungoides and Sézary syndrome.
    Bachelez H; Bioul L; Flageul B; Baccard M; Moulonguet-Michau I; Verola O; Morel P; Dubertret L; Sigaux F
    Arch Dermatol; 1995 Sep; 131(9):1027-31. PubMed ID: 7661604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA expression in Sezary syndrome: identification, function, and diagnostic potential.
    Ballabio E; Mitchell T; van Kester MS; Taylor S; Dunlop HM; Chi J; Tosi I; Vermeer MH; Tramonti D; Saunders NJ; Boultwood J; Wainscoat JS; Pezzella F; Whittaker SJ; Tensen CP; Hatton CS; Lawrie CH
    Blood; 2010 Aug; 116(7):1105-13. PubMed ID: 20448109
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sézary T-cell-activating factor induces functional interleukin 2 receptors on T-cells derived from patients with Sézary syndrome.
    Abrams JT; Ghosh SK; DeFreitas E
    Cancer Res; 1993 Nov; 53(22):5501-6. PubMed ID: 8221690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The Sézary syndrome].
    Ferreira F; Correia TM; Callabro L; Andrade J
    Acta Med Port; 1998 Dec; 11(12):1135-9. PubMed ID: 10192992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential expression of TOX by skin-infiltrating T cells in Sézary syndrome and erythrodermic dermatitis.
    Boonk SE; Çetinözman F; Vermeer MH; Jansen PM; Willemze R
    J Cutan Pathol; 2015 Sep; 42(9):604-9. PubMed ID: 25777533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. FOXP3+CD25- tumor cells with regulatory function in Sézary syndrome.
    Heid JB; Schmidt A; Oberle N; Goerdt S; Krammer PH; Suri-Payer E; Klemke CD
    J Invest Dermatol; 2009 Dec; 129(12):2875-85. PubMed ID: 19626037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytologic evaluation of lymphadenopathy associated with mycosis fungoides and Sezary syndrome: role of immunophenotypic and molecular ancillary studies.
    Pai RK; Mullins FM; Kim YH; Kong CS
    Cancer; 2008 Oct; 114(5):323-32. PubMed ID: 18798522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.